Ledger.Open graph →
SEC Form D · filed December 21, 2023

Ratio Therapeutics, Inc

Offering
$50.7M
Sold
$50.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Allan W. Green · Boston, MADirectorShawn W. Hillier · Boston, MAExecAlbert W. Holman · Boston, MADirectorMatthias W. Friebe · Boston, MAExecJohn W. Hoppin · Boston, MAExec · DirectorJacob W. Hesterman · Boston, MAExecJohn W. Babich · Boston, MAExec · DirectorReed W. Malleck · Boston, MAExecScott W. Holbrook · Boston, MADirectorJohn W. Garvey · Boston, MAExecSusan W. Whoriskey · Boston, MADirectorAllan W. Green · Boston, MADirectorShawn W. Hillier · Boston, MAExecAlbert W. Holman · Boston, MADirectorMatthias W. Friebe · Boston, MAExecJohn W. Hoppin · Boston, MAExec · DirectorJacob W. Hesterman · Boston, MAExecJohn W. Babich · Boston, MAExec · DirectorReed W. Malleck · Boston, MAExecScott W. Holbrook · Boston, MADirectorJohn W. Garvey · Boston, MAExecSusan W. Whoriskey · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗